Enveric Share Price
NASDAQ: ENVB | Healthcare$0.00
-$1.41 (--%) Enveric Stock Performance
Enveric Share Price Chart
$0.00$0.00
L
H
Enveric Quarterly Profit & Loss
All figures in USD
Enveric Annual Profit & Loss
All figures in USD
Enveric Balance Sheet
All figures in USD Million
Enveric Cash Flow
Annually
All figures in USD Million
Corporate Actions
About Enveric
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
Enveric Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $1.52 | $1.41 | +3.31% |
Oct 2026 | $1.44 | $1.36 | -7.80% |
Sep 2026 | $1.41 | $1.48 | +7.66% |
Aug 2026 | $1.57 | $1.37 | -11.61% |
Jul 2026 | $1.46 | $1.55 | +12.32% |
Jun 2026 | $2.29 | $1.38 | -39.74% |
May 2026 | $3.83 | $2.29 | -41.13% |
Apr 2026 | $2.02 | $3.89 | +94.50% |
Mar 2026 | $2.25 | $2.00 | -14.71% |
Feb 2026 | $2.74 | $2.35 | -19.42% |
Jan 2026 | $3.94 | $2.91 | -23.82% |
Dec 2025 | $6.02 | $3.82 | -34.48% |